Diagnostic biomarkers in cardiovascular disease: The proteomics approach

European Heart Journal

Volumn 33, Issue 18, 2012, Pages 2249-2251

  Doehner, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; GALECTIN 3; NATRIURETIC PEPTIDE RECEPTOR A; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; QUIESCIN Q6 SULFHYDRYL OXIDASE 1; THIOL OXIDASE; TROPONIN; UNCLASSIFIED DRUG;

ACCURACY; ACUTE HEART FAILURE; AGE; CARDIOVASCULAR RISK; COMORBIDITY; COST CONTROL; DISEASE MARKER; DYSPNEA; EMERGENCY WARD; GENOMICS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; OBESITY; OXIDATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; STROKE;

ANIMALS; FEMALE; HEART FAILURE; HUMANS; MALE; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PROTEOMICS;

EID: 84866374257     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs187     Document Type: Review

References (10)

1. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007;115:949-952. (Pubitemid 46328287)
2. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011;123:551-565.
3. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases Emerging Risk Factors the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408-2416.
4. Maisel AS, Choudhary R. Biomarkers in acute heart failure\state of the art. Nat Rev Cardiol 2012; Advance Access published 1 May 2012, doi:10.1038/nrcardio.2012.60.
5. Mebazaa A, Vanpoucke G, Thomas G, Verleysen K, Cohen-Solal A, Vanderheyden M, Bartunek J, Mueller C, Launay J-M, Van Landuyt N, D'hondt F, Verschuere E, Vanhaute C, Tuytten R, Vanneste L, De Cremer K, Wuyt J, Davies H, Moerman P, Logeart D, Collet C, Lortat-Jacob B, Tavares M, Laroy W, Januzzi JL, Samuel J-L, Kas K. Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur Heart J 2012;33:2317-2324.
6. de Andrade CR, Stolf BS, Debbas V, Rosa DS, Kalil J, Coelho V, Laurindo FR. Quiescin sulfhydryl oxidase (QSOX) is expressed in the human atheroma core: possible role in apoptosis. In Vitro Cell Dev Biol Anim 2011;47:716-727.
7. Morel C, Adami P, Musard JF, Duval D, Radom J, Jouvenot M. Involvement of sulf-hydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis. Exp Cell Res 2007;313:3971-3982. (Pubitemid 350010932)
8. Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos L, Steck A, Engelter S, Müller B, Christ-Crain M, Katan M. Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 2010;41:1564-1567.
9. Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol 2010;56:1045-1053.
10. Doehner W, von Haehling S, Suhr J, Schuster A, Nagel E, Melms A, Wurster T, Stellos K, Gawaz M, Bigalke B. Elevated plasma levels of neuropeptide proenke-phalin A predict mortality and functional outcome in ischemic stroke. J Am Coll Cardiol 2012;in press.